Barts and The London HIV Service | HIV clinical research

This research department in the Grahame Hayton Unit has become one of the most active in the country within HIV clinical research. We are always recruiting to different research trials which means that we can offer new and innovative treatment strategies to our patients as soon as they become available.
Currently the main areas of research are divided into two groups:
Neutralising antibodies
Our second main area of research involves working with Professor Aine McKnight, a Clinical Scientist working at Queen Mary’s Medical School here at Barts and The London. Together we are part of the Bill and Melinda Gates grant to study neutralising antibodies in HIV across viral subtypes within East London.
Different strains of HIV can be sub grouped according to genes. For example, HIV-1 group M is the most common subtype globally, but the group is further divided into subtypes A, B, C and D – subtype B is the most common in the UK. Some studies have shown that these different subtypes can have different effects on HIV transmission, development of resistance and disease progression. This research has now evolved to include work on what suppresses the virus across all groups.
The team includes:
If you are interested in participating in a clinical trial in this unit please contact:
James Hand: 020 7377 7457 or e-mail james.hand@bartsandthelondon.nhs.uk